Concepedia

164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors

Monica Sharma, Richard D. Carvajal, Glenn J. Hanna, Yoon‐Koo Kang, J. Lee, K.W. Lee, B.T. Li, Kathleen N. Moore, Mark D. Pegram, Drew Rasco,

Annals of Oncology · 2021 · 10 citations · 0 references

Open access